Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Phase 2 APPLAUDS Trial to Test Mivelsiran in Down Syndrome-Associated Alzheimer Disease
2
NeuroVoices: Jeff Dage, PhD, on Clinical Implementation of Blood-Based Biomarkers in Alzheimer Disease
3
Baseline Tau Burden Linked to Reduced Amyloid Clearance With Gantenerumab in New GRADUATE Analysis
4
Repurposed Cancer Drug Lenalidomide Shows Feasibility and Safety in Phase 2 Study of MCI Due to Alzheimer Disease
5